This filing announces MeridianMade's acquisition of Perrigo's infant formula business, with Jefferies LLC acting as financial advisor to MeridianMade. The transaction, expected to close in H1 2027, signifies a strategic divestiture for Perrigo and a growth opportunity for MeridianMade, potentially impacting their respective market valuations and future operational focus.
Perrigo Company plc is divesting its infant formula business to MeridianMade, a move that allows Perrigo to streamline its operations and focus on its core pharmaceutical and consumer health businesses. For MeridianMade, this acquisition represents a significant expansion into the infant formula market. The long closing timeline (H1 2027) suggests a complex transaction with potential regulatory hurdles, but also provides ample time for both companies to plan their transitions. Traders should monitor Perrigo for strategic shifts post-divestiture and MeridianMade for its integration plans, as this could impact their long-term growth trajectories and market positioning. The involvement of major financial advisors like Jefferies and Goldman Sachs underscores the deal's significance.